Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies.

OBJECTIVES This study sought to perform a weighted meta-analysis of the complication risk during chronic total occlusion (CTO) percutaneous coronary intervention (PCI). BACKGROUND The safety profile of CTO PCI has received limited study. METHODS We conducted a meta-analysis of 65 studies published between 2000 and 2011 reporting procedural complications of CTO PCI. Data on the frequency of death, emergent coronary artery bypass graft surgery, stroke, myocardial infarction, perforation, tamponade, stent thrombosis, major vascular or bleeding events, contrast nephropathy, and radiation skin injury were collected. RESULTS A total of 65 studies with 18,061 patients and 18,941 target CTO vessels were included. Pooled estimates of outcomes were as follows: angiographic success 77% (95% confidence interval [CI]: 74.3% to 79.6%); death 0.2% (95% CI: 0.1% to 0.3%); emergent coronary artery bypass graft surgery 0.1% (95% CI: 0.0% to 0.2%); stroke <0.01% (95% CI: 0.0% to 0.1%); myocardial infarction 2.5% (95% CI: 1.9% to 3.0%); Q-wave myocardial infarction 0.2% (95% CI: 0.1% to 0.3%); coronary perforation 2.9% (95% CI: 2.2% to 3.6%); tamponade 0.3% (95% CI: 0.2% to 0.5%); and contrast nephropathy 3.8% (95% CI: 2.4% to 5.3%). Compared with successful procedures, unsuccessful procedures had higher rates of death (0.42% vs. 1.54%, p < 0.0001), perforation (3.65% vs. 10.70%, p < 0.0001), and tamponade (0% vs. 1.65%, p < 0.0001). Among 886 lesions treated with the retrograde approach, success rate was 79.8% with no deaths and low rates of emergent coronary artery bypass graft surgery (0.17%) and tamponade (1.2%). CONCLUSIONS CTO PCI carries low risk for procedural complications despite high success rates.

[1]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[2]  K. Kent,et al.  Management and outcomes of coronary artery perforation during percutaneous coronary intervention. , 2006, The American journal of cardiology.

[3]  K. Harjai,et al.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.

[4]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[5]  Subhash Banerjee,et al.  Subintimal dissection/reentry strategies in coronary chronic total occlusion interventions. , 2012, Circulation. Cardiovascular interventions.

[6]  C. Buller,et al.  The retrograde technique for recanalization of chronic total occlusions: a step-by-step approach. , 2012, JACC. Cardiovascular interventions.

[7]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[8]  B. Rutherford,et al.  Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. , 2001, Journal of the American College of Cardiology.

[9]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[10]  G. Wright,et al.  Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. , 2012, Journal of the American College of Cardiology.

[11]  D. Stakos,et al.  Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. , 2013, International journal of cardiology.

[12]  A. Shroff,et al.  Reporting of radiation exposure in contemporary interventional cardiology trials , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  B. Gersh.  Trends in Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions: A 25-Year Experience From the Mayo Clinic , 2008 .

[14]  J. Afilalo,et al.  Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. , 2010, American heart journal.

[15]  G. Stone,et al.  Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. , 2000, Journal of the American College of Cardiology.

[16]  Subhash Banerjee,et al.  The retrograde approach to coronary artery chronic total occlusions , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[18]  C. Wong,et al.  Distal coronary artery perforation resulting from the use of hydrophilic coated guidewire in tortuous vessels. , 1998, Catheterization and cardiovascular diagnosis.

[19]  S. Weisbord,et al.  Strategies for the prevention of contrast-induced acute kidney injury , 2010, Current opinion in nephrology and hypertension.

[20]  J. Spertus,et al.  Chronic total occlusion angioplasty in the United States. , 2009, JACC. Cardiovascular interventions.

[21]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[22]  Marino Labinaz,et al.  Contrast-induced nephropathy and long-term adverse events: cause and effect? , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[23]  Subhash Banerjee,et al.  Complications of Chronic Total Occlusion Angioplasty. , 2012, Interventional cardiology clinics.

[24]  C. Di Mario,et al.  In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[25]  T. Ryan,et al.  Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry. , 1993, Journal of the American College of Cardiology.

[26]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[27]  Sunil V. Rao,et al.  Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR). , 2008, Journal of the American College of Cardiology.

[28]  Sunil V. Rao,et al.  Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry , 2009, Circulation. Cardiovascular interventions.

[29]  N. Weissman,et al.  Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. , 2003, The American journal of cardiology.

[30]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.